CD163 and COVID-19: We next tested whether the proportion of CD163/LGMN Macrophages was associated with decreased ventilator-free days, given that this subset has recently been associated with a “pro-fibrotic” phenotype in patients with severe COVID-19 or idiopathic pulmonary fibrosis10,32.